Monday, July 20, 2015

          Q & A with Kevin Sciarani '14

          This recent grad is excelling at Robbins Geller Rudman & Dowd, one of the nation's top securities litigation firms.
          Sample alt tag.

          Tell us about your current position.

          I am an associate at Robbins Geller Rudman & Dowd.  The firm specializes in representing investors in securities litigation.  I work on a small team of lawyers preparing cases for trial and settlement.  Expectations are high and it comes with added responsibility. 

          How did your time at UC Hastings prepare you for your career?

          UC Hastings professors were always willing to push students to think about complex issues rather than regurgitating the black letter law.  Although it was frustrating at exam time, practicing deeper level analysis better prepared me for thinking through issues at work.  I also took advantage of the central location and found excellent work experience at courts and agencies at both the Federal and State level. 

          Beyond purely practical skills, professors and the staff dedicated significant time to help me develop professional skills that are important for success, but not a focus of traditional legal education. 

          Why did you decide to go into law in the first place?

          I was motivated by a desire to fight for economic fairness.  However, making the decision to go to law school was a gradual process.  I knew I wanted to be a lawyer once I realized I spent my free time reading and thinking of solutions to problems.  Now I get to do this almost every day. 

          What is your greatest professional accomplishment so far?

          As a new lawyer, seeing my written work being used in motion briefs is most satisfying.    

          What’s your approach to work/life balance?

          First, I think you should be realistic and accept that there will be times that work/life balance may seem impossible in many legal jobs.  But I try to identify what is really important in my life and what is just a bonus.  I obsessively schedule my time to try to find time for the important things.  I always look to find ways to increase my efficiency in handling mundane tasks to have more time for the things I enjoy.


          SHARELINE: "@uchastingslaw profs push students to think about complex issues rather than regurgitating the black letter law." http://ctt.ec/mbKdQ+


          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, November 20, 2017

          Professor Carol Izumi receives 2018 William Pincus Award for Outstanding Service and Commitment to Clinical Legal Education from the Association of American Law Schools (AALS)

          “Recipients are giants in the field and Carol belongs in their midst,” says Associate Dean Ascanio Piomelli.
          Friday, November 17, 2017

          Exciting New Spring 2018 Courses Focus on the Future

          Grabbing from the headlines and emphasizing innovation, courses like Legal Tech Startups, Advanced Immigration Law, and Stalking and Law will prepare UC Hastings students for next-level legal careers.
          Tuesday, November 14, 2017

          Port pilot John Betz ’96 discusses his non-legal career and the importance of education

          A tragic “Deadliest Catch” moment piqued a lifelong interest in the law and encouraged John to pursue a law degree at UC Hastings.
          Friday, November 03, 2017

          Thinkers & Doers: October 2017

          100 Things Warriors Fans Should Know & Do Before They Die -- Alum appointed Chargé d’Affaires -- The poisonous dynamic over who’s to blame for racism -- Prof. Williams on the Harvey Weinstein Effect -- Two More UC Hastings Grads Receive Judgeships from Gov. Brown -- Jury selection in the Steinle case -- and much more
          Wednesday, November 01, 2017

          Why do drug prices remain so high?

          "Because drug companies block competition," says Professor Feldman in a new study that examines all drugs on the market between 2005 and 2015, identifying and analyzing every instance in which the company added new patents or exclusivities. 
          Go to News Archive